Clinical Trial Update: Quantitative Fluorescence Molecular Imaging of Ustekinumab-800CW to Elucidate the Drug Distribution Throughout Inflamed Tissue in Crohn's Disease and Psoriasis. [Phase 1]

View source ↗

Summary

Phase 1 study using a fluorescently labeled form of ustekinumab (Ustekinumab-800CW) to visualize and quantify how the drug distributes in inflamed tissue for Cr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis

Drugs mentioned

• Ustekinumab-800CW

Snippet

Sponsor: University Medical Center Groningen | Conditions: Psoriasis, Crohn Disease | Phase 1 | Status: RECRUITING